Advertisement

Combined management of retroperitoneal sarcoma with dose intensification radiotherapy and resection: Long-term results of a prospective trial

Published:January 09, 2014DOI:https://doi.org/10.1016/j.radonc.2013.10.041

      Abstract

      Background

      Late failure is a challenging problem following resection of retroperitoneal sarcoma (RPS). We investigated the effects of preoperative XRT plus dose escalation with early postoperative brachytherapy (BT) on long-term survival and recurrence in RPS.

      Methods

      From June 1996 to October 2000, eligible patients with resectable RPS were entered onto a phase II trial of preoperative XRT (45–50 Gray) plus postoperative BT (20–25 Gray). Kaplan Meier survival curves were constructed and compared by log rank analysis (SPSS 21.0).

      Results

      All 40 patients had preoperative XRT and total gross resection as part of the prospective trial, nineteen received BT (48%). Median follow-up was 106 months. For the entire cohort, OS at 5 and 10 years was 70% and 64%, respectively; RFS at 5 and 10 years was 69% and 63%. RFS was significantly reduced in high versus low grade RPS at 5 years (53% vs. 88%, p = 0.016), but not at 10 years (53% vs. 75%, p = 0.079). RFS and OS at 10 years were reduced in patients who presented with recurrent compared to primary disease (RFS 30% vs. 74%, p = 0.015; OS 36% vs. 76%, p = 0.036). At 10 years, neither RFS nor OS was improved in patients who received BT compared to those who did not (RFS 56% vs. 69%, p = 0.54; OS 52% vs.76%, p = 0.23).

      Conclusions

      In this prospective trial with mature follow-up, long-term OS and RFS in patients who underwent combined preoperative XRT plus resection of RPS compare favourably with those reported in retrospective institutional and population-based series. Postoperative BT was associated with unacceptable toxicity and did not contribute to disease control.

      Condensed abstract

      In a prospective trial with mature follow-up, preoperative radiation combined with complete resection of retroperitoneal sarcoma resulted in favourable long-term RFS and OS compared to historical controls. Dose escalation with postoperative brachytherapy was not associated with better disease control.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Radiotherapy and Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Swallow C.J.
        • Catton C.N.
        Local management of adult soft tissue sarcomas.
        Semin Oncol. 2007; 34: 256-269
        • Neuhaus S.J.
        • Barry P.
        • Clark M.A.
        • Hayes A.J.
        • Fisher C.
        • Thomas J.M.
        Surgical management of primary and recurrent retroperitoneal liposarcoma.
        Br J Surg. 2005; 92: 246-252
        • Stojadinovic A.
        • Yeh A.
        • Brennan M.F.
        Completely resected recurrent soft tissue sarcoma: primary anatomic site governs outcomes.
        J Am Coll Surg. 2002; 194: 436-447
        • Catton C.N.
        • O’Sullivan B.
        • Kotwall C.
        • Cummings B.
        • Hao Y.
        • Fornasier V.
        Outcome and prognosis in retroperitoneal soft tissue sarcoma.
        Int J Radiat Oncol Biol Phys. 1994; 29: 1005-1010
        • Heslin M.J.
        • Lewis J.J.
        • Nadler E.
        • et al.
        Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management.
        J Clin Oncol. 1997; 15: 2832-2839
        • Singer S.
        • Corson J.M.
        • Demetri G.D.
        • Healey E.A.
        • Marcus K.
        • Eberlein T.J.
        Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma.
        Ann Surg. 1995; 221: 185-195
        • Nathan H.
        • Raut C.P.
        • Thornton K.
        • et al.
        Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system.
        Ann Surg. 2009; 250: 970-976
        • Bonvalot S.
        • Miceli R.
        • Berselli M.
        • et al.
        Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control.
        Ann Surg Oncol. 2010; 17: 1507-1514
        • Gronchi A.
        • Miceli R.
        • Colombo C.
        • et al.
        Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas.
        Ann Oncol. 2011; 23: 1067-1073
        • Pisters P.W.
        • Harrison L.B.
        • Leung D.H.
        • Woodruff J.M.
        • Casper E.S.
        • Brennan M.F.
        Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma.
        J Clin Oncol. 1996; 14: 859-868
        • Yang J.C.
        • Chang A.E.
        • Baker A.R.
        • et al.
        Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.
        J Clin Oncol. 1998; 16: 197-203
        • Tzeng C.W.
        • Fiveash J.B.
        • Popple R.A.
        • et al.
        Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma.
        Cancer. 2006; 107: 371-379
        • Van De Voorde L.
        • Delrue L.
        • van Eijkeren M.
        • De Meerleer G.
        Radiotherapy and surgery-an indispensable duo in the treatment of retroperitoneal sarcoma.
        Cancer. 2011; 117: 4355-4364
        • Pollack A.
        • Zagars G.K.
        • Goswitz M.S.
        • Pollock R.A.
        • Feig B.W.
        • Pisters P.W.
        Preoperative vs. postoperative radiotherapy in the treatment of soft tissue sarcomas: a matter of presentation.
        Int J Radiat Oncol Biol Phys. 1998; 42: 563-572
        • Jones J.J.
        • Catton C.N.
        • O’Sullivan B.
        • et al.
        Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma.
        Ann Surg Oncol. 2002; 9: 346-354
        • Nag S.
        • Shasha D.
        • Janjan N.
        • Petersen I.
        • Zaider M.
        The American Brachytherapy Society recommendations for brachytherapy of soft tissue sarcomas.
        Int J Radiat Oncol Biol Phys. 2001; 49: 1033-1043
        • Alektiar K.M.
        • Brennan M.F.
        • Singer S.
        Local control comparison of adjuvant brachytherapy to intensity-modulated radiotherapy in primary high-grade sarcoma of the extremity.
        Cancer. 2011; 117: 3229-3234
        • Dziewirski W.
        • Rutkowski P.
        • Nowecki Z.I.
        • et al.
        Surgery combined with intraoperative brachytherapy in the treatment of retroperitoneal sarcomas.
        Ann Surg Oncol. 2006; 13: 245-252
        • Bonvalot S.
        • Raut C.P.
        • Pollock R.E.
        • et al.
        Technical considerations in surgery for retroperitoneal sarcomas: position paper from E-surge, a master class in sarcoma surgery, and EORTC-STBSG.
        Ann Surg Oncol. 2012; 19: 2981-2991
        • Bonvalot S.
        • Rivoire M.
        • Castaing M.
        • et al.
        Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control.
        J Clin Oncol. 2009; 27: 31-37
        • Gronchi A.
        • Bonvalot S.
        • Le Cesne A.
        • Casali P.G.
        Resection of uninvolved adjacent organs can be part of surgery for retroperitoneal soft tissue sarcoma.
        J Clin Oncol. 2011; 27 ([author reply 2107–2108]): 2106-2107
        • Gronchi A.
        • Pollock R.
        Surgery in retroperitoneal soft tissue sarcoma: a call for a consensus between Europe and North America.
        Ann Surg Oncol. 2011; 18: 2107-2110
        • Strauss D.C.
        • Hayes A.J.
        • Thway K.
        • Moskovic E.C.
        • Fisher C.
        • Thomas J.M.
        Surgical management of primary retroperitoneal sarcoma.
        Br J Surg. 2010; 97: 698-706
        • Pisters P.W.
        Resection of some – but not all – clinically uninvolved adjacent viscera as part of surgery for retroperitoneal soft tissue sarcomas.
        J Clin Oncol. 2009; 27: 6-8
        • Sindelar W.F.
        • Kinsella T.J.
        • Chen P.W.
        • et al.
        Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial.
        Arch Surg. 1993; 128: 402-410
        • Issels R.D.
        • Lindner L.H.
        • Verweij J.
        • et al.
        Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.
        Lancet Oncol. 2010; 11: 561-570
        • Pawlik T.M.
        • Pisters P.W.
        • Mikula L.
        • et al.
        Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma.
        Ann Surg Oncol. 2006; 13: 508-517
        • Llacer-Moscardo C.
        • Quenet F.
        • Azria D.
        • Fenoglietto P.
        Feasibility study of volumetric modulated arc therapy for the treatment of retroperitoneal sarcomas.
        Radiat Oncol. 2010; 5: 83
        • Robertson J.M.
        • Sondak V.K.
        • Weiss S.A.
        • Sussman J.J.
        • Chang A.E.
        • Lawrence T.S.
        Preoperative radiation therapy and iododeoxyuridine for large retroperitoneal sarcomas.
        Int J Radiat Oncol Biol Phys. 1995; 31: 87-92
        • Paumier A.
        • Le Pechoux C.
        • Beaudre A.
        • et al.
        IMRT or conformal radiotherapy for adjuvant treatment of retroperitoneal sarcoma?.
        Radiother Oncol. 2011; 99: 73-78
        • Gronchi A.
        • Lo Vullo S.
        • Fiore M.
        • et al.
        Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients.
        J Clin Oncol. 2008; 27: 24-30
        • Canter R.J.
        • Qin L.X.
        • Ferrone C.R.
        • Maki R.G.
        • Singer S.
        • Brennan M.F.
        Why do patients with low-grade soft tissue sarcoma die?.
        Ann Surg Oncol. 2008; 15: 3550-3560
        • Koenig A.M.
        • Reeh M.
        • Burdelski C.M.
        • et al.
        Long-term results of primary and secondary resections in patients with retroperitoneal soft tissue sarcoma.
        Langenbecks Arch Surg. 2012; 397: 1251-1259
        • Delaney T.F.
        Radiation therapy: neoadjuvant, adjuvant, or not at all.
        Surg Oncol Clin N Am. 2012; 21: 215-241
        • Paryani N.N.
        • Zlotecki R.A.
        • Swanson E.L.
        • et al.
        Multimodality local therapy for retroperitoneal sarcoma.
        Int J Radiat Oncol Biol Phys. 2011; 82: 1128-1134
        • Lewis J.J.
        • Leung D.
        • Woodruff J.M.
        • Brennan M.F.
        Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution.
        Ann Surg. 1998; 228: 355-365
        • Singer S.
        • Antonescu C.R.
        • Riedel E.
        • Brennan M.F.
        Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.
        Ann Surg. 2003; 238 ([discussion 370–351]): 358-370
        • Stoeckle E.
        • Coindre J.M.
        • Bonvalot S.
        • et al.
        Prognostic factors in retroperitoneal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group.
        Cancer. 2001; 92: 359-368
        • Dalal K.M.
        • Kattan M.W.
        • Antonescu C.R.
        • Brennan M.F.
        • Singer S.
        Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.
        Ann Surg. 2006; 244: 381-391
        • Zlotecki R.A.
        • Katz T.S.
        • Morris C.G.
        • Lind D.S.
        • Hochwald S.N.
        Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma: the University of Florida experience.
        Am J Clin Oncol. 2005; 28: 310-316
        • Alektiar K.M.
        • Hu K.
        • Anderson L.
        • Brennan M.F.
        • Harrison L.B.
        High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas.
        Int J Radiat Oncol Biol Phys. 2000; 47: 157-163